Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor + G-CSF Mobilization in NHL and MM
NCT00322842Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in non-Hodgkin lymphoma (NHL), multiple myeloma (MM), sponsored by Sanofi. Started Sep 2004; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00322842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322842.